Valuation dashboard for Dare Bioscience, Inc. (DARE) with P/E N/A, P/B -18.96, EV/EBITDA -0.53 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis.
Analysis Summary
Trailing-twelve-month margins: gross margin -89.5%, operating margin -8.1%, net margin -8.0%.
At the current price of $0.73, DARE has negative trailing earnings (P/E not meaningful) and an ROE of -7.48%. Market capitalisation stands at $11M.
Balance sheet quality for DARE: current ratio of 1.1. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | -18.96 |
| EV / EBITDA | -0.53 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $0.18 |
| vs Current Price | -75.6% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| DARE | Dare Bioscience, Inc. | $11M | -7.5% | ||
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.6B | 29.76 | 6.46 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $0.73 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -748.08% |
| Return on Invested Capital | -179.10% |
| Return on Assets | -49.12% |
| Gross Margin | -89.45% |
| Operating Margin | -813.38% |
| Net Margin | -804.37% |
Related companies: ADTX · AIMD · ANL · ASBP · ATHA · CTXR · FBLG
Explore sector: Healthcare · Biotechnology
More sections of DARE: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks